Associations of Ki-ras Proto-oncogene Mutation and p53 Gene Overexpression in Sporadic Colorectal Adenomas with Demographic and Clinicopathologic Characteristics
Open Access
- 2 August 2006
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 15 (8) , 1443-1450
Abstract
In colorectal tumorigenesis, Ki-ras proto-oncogene mutation often occurs early in the adenoma-adenocarcinoma sequence, whereas mutation of the p53 gene is associated with late progression to carcinoma. We evaluated the relationship of demographic and clinicopathologic characteristics to Ki-ras mutation and p53 gene product overexpression in 1,093 baseline sporadic colorectal adenomas from 926 individuals enrolled in a phase III recurrence prevention trial. Ki-ras mutation was found in 14.7% of individuals and p53 overexpression was found in 7.0% of those tested. Multivariate analysis found older age, rectal location, and villous histology to be independently associated with Ki-ras mutation. Individuals with an advanced adenoma (≥1 cm or high-grade dysplasia or villous histology) had a 4-fold higher likelihood of Ki-ras mutation [odds ratios (OR), 3.96; 95% confidence intervals (CI), 2.54-6.18]. Ki-ras mutations in codon 12 and of the G-to-A transition type were more frequent in older individuals, whereas G-to-T transversion was more frequent in rectal adenomas than in the colon. Multivariate analysis showed that previous history of a polyp (P = 0.03) was inversely associated with p53 overexpression. Large adenoma size (≥1 cm), high-grade dysplasia, and villous histology were independently associated with p53 overexpression, with the strongest association for advanced adenomas (OR, 7.20; 95% CI, 3.01-17.22). Individuals with a Ki-ras mutated adenoma were more likely to overexpress p53 (OR, 2.46; 95% CI, 1.36-4.46), and 94.8% of adenomas with both alterations were classified as advanced (P ≤ 0.0001). Our large cross-sectional study supports the role of both Ki-ras and p53 in the progression of adenomas and shows that their molecular pathogenesis differs by anatomic location, age, and mucosal predisposition as evidenced by previous history of a polyp. (Cancer Epidemiol Biomarkers Prev 2006;15(8):1443–50)Keywords
This publication has 79 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001
- K-ras mutations, rectal crypt cells proliferation, and meat consumption in patients with left-sided colorectal carcinomaEuropean Journal Of Cancer Prevention, 2000
- Genetic epidemiology of mutated K- ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomasGut, 1999
- Adenoma-Carcinoma Sequence of ColorectumDiagnostic Molecular Pathology, 1995
- p53 gene mutations in early colorectal carcinoma. de novo vs. adenoma‐carcinoma sequenceInternational Journal of Cancer, 1995
- Lower Incidence of K‐ras Codon 12 Mutation in Flat Colorectal Adenomas than in Polypoid AdenomasJapanese Journal of Cancer Research, 1994
- Getting a Handle on Ras ActivityScience, 1992
- Higher Frequency of Point Mutations in the c‐K‐ras2 Gene in Human Colorectal Adenomas with Severe Atypia than in CarcinomasJapanese Journal of Cancer Research, 1991
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988